H. Kitagawa

发表

A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer

S. Kudoh, T. Yamanaka, M. Fukuoka, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.